Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identifying the Prevalence, Severity and the Impact on Quality of Life of Long-term Ototoxicity in Cancer Survivors: a Cross-sectional Study

NCT04270916 is registered in ClinicalTrials.gov with University of Nottingham as lead sponsor.

NCT NCT04270916
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04270916 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identifying the Prevalence, Severity and the Impact on Quality of Life of Long-term Ototoxicity in Cancer Survivors: a Cross-sectional Study
Lead sponsor
University of Nottingham
Phase
Observational
Overall status
Suspended
Start date
February 3, 2020
Completion date
September 30, 2020
Enrollment
46 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, chemotherapeutic toxicity, hearing loss, sensorineural, tinnitus, subjective